7-45890551-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000596.4(IGFBP1):c.353C>A(p.Ala118Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000504 in 1,607,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000596.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IGFBP1 | NM_000596.4 | c.353C>A | p.Ala118Glu | missense_variant | 2/4 | ENST00000275525.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IGFBP1 | ENST00000275525.8 | c.353C>A | p.Ala118Glu | missense_variant | 2/4 | 1 | NM_000596.4 | P4 | |
IGFBP1 | ENST00000457280.5 | c.353C>A | p.Ala118Glu | missense_variant | 2/4 | 5 | A2 | ||
IGFBP1 | ENST00000468955.1 | c.353C>A | p.Ala118Glu | missense_variant | 2/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000450 AC: 11AN: 244388Hom.: 0 AF XY: 0.0000379 AC XY: 5AN XY: 131998
GnomAD4 exome AF: 0.0000502 AC: 73AN: 1454868Hom.: 0 Cov.: 31 AF XY: 0.0000567 AC XY: 41AN XY: 723622
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.353C>A (p.A118E) alteration is located in exon 2 (coding exon 2) of the IGFBP1 gene. This alteration results from a C to A substitution at nucleotide position 353, causing the alanine (A) at amino acid position 118 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at